Differential Presentation of Protein Interaction Surfaces on the Androgen Receptor Defines the Pharmacological Actions of Bound Ligands
- 23 April 2009
- journal article
- Published by Elsevier in Chemistry & Biology
- Vol. 16 (4) , 452-460
- https://doi.org/10.1016/j.chembiol.2009.01.016
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Expanding the therapeutic use of androgens via selective androgen receptor modulators (SARMs)Drug Discovery Today, 2007
- Structure of the ligand-binding domain (LBD) of human androgen receptor in complex with a selective modulator LGD2226Acta Crystallographica Section F Structural Biology and Crystallization Communications, 2006
- Effects of Tamoxifen vs Raloxifene on the Risk of Developing Invasive Breast Cancer and Other Disease OutcomesThe NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 TrialJAMA, 2006
- Androgen receptor–cofactor interactions as targets for new drug discoveryTrends in Pharmacological Sciences, 2005
- Single-step purification of full-length human androgen receptorNuclear Receptor Signaling, 2005
- Discovery of novel nuclear receptor modulating ligands: an integral role for peptide interaction profilingDrug Discovery Today, 2004
- The FXXLF Motif Mediates Androgen Receptor-specific Interactions with CoregulatorsJournal of Biological Chemistry, 2002
- Peptide Antagonists of the Human Estrogen ReceptorScience, 1999
- Discovery of Nonsteroidal AndrogensBiochemical and Biophysical Research Communications, 1998
- Hierarchical Grouping to Optimize an Objective FunctionJournal of the American Statistical Association, 1963